Better Solutions for Healthcare

NYT: Dialysis Patients Face Close-Up Risk From Coronavirus

By Reed Abelson

March 11, 2020

Mat Risher leaves the safety of his home near Seattle three days a week for dialysis at a clinic, a treatment he cannot live without but one that now most likely increases his risk of exposure to the coronavirus.

About 20 patients sit in a small space with him, tethered for several hours to machines that filter toxins from their blood. All now have their temperatures taken before they enter. They can wear a surgical mask and are told that the rooms are cleaned and machinery disinfected regularly.

One of the first people to die from the virus in the United States had received dialysis at the very same clinic, information that triggered a panic attack in Mr. Risher.

As the coronavirus rages from state to state, the 500,000 people whose failing kidneys require them to get dialysis are among the most vulnerable. Each clinic may have dozens of patients during a single shift, often sitting less than the recommended six feet apart for hours.

“It’s definitely a scary time for us,” said Mr. Risher, 33, of Everett, Wash.

Kidney dialysis is a last resort for many people, and they are endemically susceptible to infection in normal times. The dialysis industry has historically had a poor record when it comes to infection control so the current infectious climate is fraught with worry.

DaVita and Fresenius, the two for-profit companies that dominate the industry, say they have procedures in place to keep their patients and staff safe and say they have taken aggressive steps in recent weeks to prevent the spread of the virus at their facilities. “We’re all playing in real time, and we’re doing our best,” said Javier Rodriguez, the chief executive of DaVita.

DaVita and Fresenius claim they have had no significant outbreaks to date. Fresenius says less than half of 1 percent of its patients and staff have tested positive for the virus. “We’ve been remarkably successful in mitigating cross-contamination,” said Bill Valle, the chief executive of Fresenius Medical Care North America, which is a unit of the German company.

“None of the services we provide are elective in nature,” he said.

DaVita would not say how many of its patients or staff have become infected. “At this time,” the company said, “we are not disclosing specific numbers for a variety of reasons, ranging from our desire to focus on both the mental and physical health of our patients and teammates, to the fact that things change frequently in this dynamic situation.”

Critics of the large chains say the companies are not taking the threat seriously enough. Health care workers are concerned about protective equipment, with patients being asked to reuse masks and scattered shortages of the most protective gear for the nurses and technicians dealing with infected patients.

“When it comes to responding to Covid-19, the response by large dialysis organizations has been inadequate, leaving some of the most vulnerable exposed to Covid-19, which is especially serious in people with end-stage renal disease,” said Dave Regan, president of the Service Employees International Union-United Healthcare Workers West, in a statement.

Representative Katie Porter, Democrat of California, also wrote both companies in late March to ask what steps they were taking. “We are concerned that DaVita, specifically, has failed thus far to understand the severity of this outbreak and the high transmission of the virus,” she said.

In particular, she criticized DaVita for going ahead with an annual meeting of medical directors in early March, where one of the attendees later tested positive for the virus. In its response to Ms. Porter, DaVita defended the decision as being appropriate at the time and said no one appears to have been sickened as a result.

Infection has traditionally been one of the industry’s biggest problems.

“The second leading cause of death among hemodialysis patients is infections,” said Dr. Alan Kliger, a Yale nephrologist who is leading efforts to control the spread of coronavirus among dialysis patients. As many as one in 10 patients die from complications from an infection, often at the site where a patient has a catheter.

According to an analysis of Medicare data by the research department of the union, six out of 10 facilities undergoing routine inspections last year were cited for deficiencies involving infection control. Examples would include a staff member failing to wear gloves during a procedure or to properly clean equipment.

At this juncture, with the highly infectious coronavirus, others are extremely concerned about the spread of the virus through inadequate supplies of special masks or gowns. “We don’t have enough of many of those protective equipments,” Dr. Kliger said.

In areas like New York and Connecticut, the surge in patients has meant heavy use of whatever supplies are available, he said. “The burn rate has been incredibly high,” he said.

Dialysis workers say they do not feel protected. One worker who asked not to be named because she might lose her job said she thought the clinic was downplaying the risk of employees getting sick. “You just don’t feel fine,” she said.

The industry is now scrambling to adopt new practices aimed at stemming potential infections. At the clinic where Mr. Risher gets treated, “We saw things change pretty immediately,” he said…